Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Economics in "Global Health 2035": a sensitivity analysis of the value of a life year estimates.

Chang AY, Robinson LA, Hammitt JK, Resch SC.

J Glob Health. 2017 Jun;7(1):010401. doi: 10.7189/jogh.07.010401.

2.

Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021.

Korenromp EL, Wi T, Resch S, Stover J, Broutet N.

PLoS One. 2017 Jan 27;12(1):e0170773. doi: 10.1371/journal.pone.0170773. eCollection 2017.

3.

Using cost-effectiveness analysis to prioritize policy and programmatic approaches to physical activity promotion and obesity prevention in childhood.

Cradock AL, Barrett JL, Kenney EL, Giles CM, Ward ZJ, Long MW, Resch SC, Pipito AA, Wei ER, Gortmaker SL.

Prev Med. 2017 Feb;95 Suppl:S17-S27. doi: 10.1016/j.ypmed.2016.10.017. Epub 2016 Oct 20.

PMID:
27773710
4.

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.

Campos NG, Sharma M, Clark A, Kim JJ, Resch SC.

PLoS One. 2016 Oct 6;11(10):e0164000. doi: 10.1371/journal.pone.0164000. eCollection 2016.

5.

State-level estimates of childhood obesity prevalence in the United States corrected for report bias.

Long MW, Ward ZJ, Resch SC, Cradock AL, Wang YC, Giles CM, Gortmaker SL.

Int J Obes (Lond). 2016 Oct;40(10):1523-1528. doi: 10.1038/ijo.2016.130. Epub 2016 Jul 27.

PMID:
27460603
6.

Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds.

Robinson LA, Hammitt JK, Chang AY, Resch S.

Health Policy Plan. 2017 Feb;32(1):141-145. doi: 10.1093/heapol/czw096. Epub 2016 Jul 24.

PMID:
27452949
7.

Cost-Effectiveness of a Model Infection Control Program for Preventing Multi-Drug-Resistant Organism Infections in Critically Ill Surgical Patients.

Jayaraman SP, Jiang Y, Resch S, Askari R, Klompas M.

Surg Infect (Larchmt). 2016 Oct;17(5):589-95. doi: 10.1089/sur.2015.222. Epub 2016 Jul 11.

PMID:
27399263
8.

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

Walensky RP, Borre ED, Bekker LG, Resch SC, Hyle EP, Wood R, Weinstein MC, Ciaranello AL, Freedberg KA, Paltiel AD.

Ann Intern Med. 2016 Sep 6;165(5):325-33. doi: 10.7326/M16-0799. Epub 2016 May 31.

9.

Redrawing the US Obesity Landscape: Bias-Corrected Estimates of State-Specific Adult Obesity Prevalence.

Ward ZJ, Long MW, Resch SC, Gortmaker SL, Cradock AL, Giles C, Hsiao A, Wang YC.

PLoS One. 2016 Mar 8;11(3):e0150735. doi: 10.1371/journal.pone.0150735. eCollection 2016.

10.

Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study.

Atun R, Chang AY, Ogbuoji O, Silva S, Resch S, Hontelez J, Bärnighausen T.

BMJ Open. 2016 Mar 6;6(3):e009656. doi: 10.1136/bmjopen-2015-009656.

11.

Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection.

Walensky RP, Jacobsen MM, Bekker LG, Parker RA, Wood R, Resch SC, Horstman NK, Freedberg KA, Paltiel AD.

J Infect Dis. 2016 May 15;213(10):1523-31. doi: 10.1093/infdis/jiv523. Epub 2015 Dec 17.

12.

Three Interventions That Reduce Childhood Obesity Are Projected To Save More Than They Cost To Implement.

Gortmaker SL, Wang YC, Long MW, Giles CM, Ward ZJ, Barrett JL, Kenney EL, Sonneville KR, Afzal AS, Resch SC, Cradock AL.

Health Aff (Millwood). 2015 Nov;34(11):1932-9. doi: 10.1377/hlthaff.2015.0631.

PMID:
26526252
13.

Crystal structure of 12-benzyl-sulfanyl-2,9-di-bromo-6H-dibenzo[b,g][1,8]naphthyridin-11-one.

Resch S, Quell T, Schollmeyer D, Waldvogel SR.

Acta Crystallogr E Crystallogr Commun. 2015 Aug 22;71(Pt 9):o675-6. doi: 10.1107/S2056989015014541. eCollection 2015 Sep 1.

14.

Functionalization of Silver Nanowires Surface using Ag-C Bonds in a Sequential Reductive Method.

Bashouti MY, Resch S, Ristein J, Mačković M, Spiecker E, Waldvogel SR, Christiansen SH.

ACS Appl Mater Interfaces. 2015 Oct 7;7(39):21657-61. doi: 10.1021/acsami.5b06830. Epub 2015 Sep 25.

PMID:
26393815
15.

The Cost of Responding to an Acinetobacter Outbreak in Critically Ill Surgical Patients.

Jiang Y, Resch S, Liu X, Rogers SO Jr, Askari R, Klompas M, Jayaraman SP.

Surg Infect (Larchmt). 2016 Feb;17(1):58-64. doi: 10.1089/sur.2015.036. Epub 2015 Sep 10.

PMID:
26356287
16.

Defeating AIDS--advancing global health.

Piot P, Abdool Karim SS, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E, Watts C, Kilonzo N, McManus J, Sidibé M; UNAIDS–Lancet Commission..

Lancet. 2015 Jul 11;386(9989):171-218. doi: 10.1016/S0140-6736(15)60658-4. Epub 2015 Jun 24. Review. No abstract available. Erratum in: Lancet. 2015 Jul 11;386(9989):136.

PMID:
26117719
17.

Cost Effectiveness of an Elementary School Active Physical Education Policy.

Barrett JL, Gortmaker SL, Long MW, Ward ZJ, Resch SC, Moodie ML, Carter R, Sacks G, Swinburn BA, Wang YC, Cradock AL.

Am J Prev Med. 2015 Jul;49(1):148-59. doi: 10.1016/j.amepre.2015.02.005.

PMID:
26094235
18.

Modeling the Cost Effectiveness of Child Care Policy Changes in the U.S.

Wright DR, Kenney EL, Giles CM, Long MW, Ward ZJ, Resch SC, Moodie ML, Carter RC, Wang YC, Sacks G, Swinburn BA, Gortmaker SL, Cradock AL.

Am J Prev Med. 2015 Jul;49(1):135-47. doi: 10.1016/j.amepre.2015.03.016. Review.

PMID:
26094234
19.

BMI and Healthcare Cost Impact of Eliminating Tax Subsidy for Advertising Unhealthy Food to Youth.

Sonneville KR, Long MW, Ward ZJ, Resch SC, Wang YC, Pomeranz JL, Moodie ML, Carter R, Sacks G, Swinburn BA, Gortmaker SL.

Am J Prev Med. 2015 Jul;49(1):124-34. doi: 10.1016/j.amepre.2015.02.026.

PMID:
26094233
20.

Cost Effectiveness of a Sugar-Sweetened Beverage Excise Tax in the U.S.

Long MW, Gortmaker SL, Ward ZJ, Resch SC, Moodie ML, Sacks G, Swinburn BA, Carter RC, Claire Wang Y.

Am J Prev Med. 2015 Jul;49(1):112-23. doi: 10.1016/j.amepre.2015.03.004. Review.

PMID:
26094232

Supplemental Content

Support Center